{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:06:33Z","timestamp":1768291593901,"version":"3.49.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.braindev.2022.02.005","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T07:46:46Z","timestamp":1646034406000},"page":"380-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes"],"prefix":"10.1016","volume":"44","author":[{"given":"Tohru","family":"Okanishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Motoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Yazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Enoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayataka","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2022.02.005_b0005","doi-asserted-by":"crossref","first-page":"106437","DOI":"10.1016\/j.yebeh.2019.07.038","article-title":"The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)","volume":"103","author":"Ross","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2022.02.005_b0010","series-title":"A Clinical Guide to Epileptic Syndromes and Their Treatment","author":"Panayiotopoulos","year":"2007"},{"issue":"s4","key":"10.1016\/j.braindev.2022.02.005_b0015","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1111\/j.1528-1157.1998.tb05123.x","article-title":"Benign epilepsy of childhood with centrotemporal spikes","volume":"39","author":"Wirrell","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2022.02.005_b0020","doi-asserted-by":"crossref","first-page":"670958","DOI":"10.3389\/fneur.2021.670958","article-title":"Treatment for the benign childhood epilepsy with centrotemporal spikes: A monocentric study","volume":"12","author":"Kessi","year":"2021","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.braindev.2022.02.005_b0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.seizure.2006.12.006","article-title":"Levetiracetam monotherapy for children and adolescents with benign rolandic seizures","volume":"16","author":"Verrotti","year":"2007","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.braindev.2022.02.005_b0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(16)30292-7","article-title":"Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial","volume":"16","author":"Baulac","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.braindev.2022.02.005_b0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yebeh.2017.04.003","article-title":"Psychiatric side effects and antiepileptic drugs: observations from prospective audits","volume":"71","author":"Stephen","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.braindev.2022.02.005_b0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/archdischild-2013-304211","article-title":"Antiepileptic drug treatment of rolandic epilepsy and Panayiotopoulos syndrome: clinical practice survey and clinical trial feasibility","volume":"100","author":"Mellish","year":"2015","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.braindev.2022.02.005_b0045","doi-asserted-by":"crossref","unstructured":"Tan HJ, Singh J, Gupta R, de Goede C. Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes. Cochrane Database Syst Rev 2014;2014:CD006779.","DOI":"10.1002\/14651858.CD006779.pub2"},{"issue":"5","key":"10.1016\/j.braindev.2022.02.005_b0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.braindev.2006.09.008","article-title":"Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial","volume":"29","author":"Coppola","year":"2007","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2022.02.005_b0055","doi-asserted-by":"crossref","first-page":"107580","DOI":"10.1016\/j.yebeh.2020.107580","article-title":"The effects of lacosamide on cognitive function and psychiatric profiles in patients with epilepsy","volume":"113","author":"Li","year":"2020","journal-title":"Epilepsy Behav"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760422000249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760422000249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:50:23Z","timestamp":1759953023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760422000249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0387760422000249"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2022.02.005","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2022.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Japanese Society of Child Neurology Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}